Roche's Alecensa wins EU panel's nod against mutated lung cancer

By John MillerZURICH, Oct 13 (Reuters) - Swiss drugmaker Roche's Alecensa has been recommended for approval in Europe as a first-line treatment for mutated......
60 Published By - dailymail.co.uk - 2017.10.13. 14:15
Share |